[HTML][HTML] PI3K/Akt/mTOR pathway and its role in cancer therapeutics: are we making headway?

Y Peng, Y Wang, C Zhou, W Mei, C Zeng - Frontiers in oncology, 2022 - frontiersin.org
Cancer is a severe public health issue that is a leading cause of mortality globally. It is also
an impediment to improving life expectancy worldwide. Furthermore, the global burden of …

Computational network biology: data, models, and applications

C Liu, Y Ma, J Zhao, R Nussinov, YC Zhang, F Cheng… - Physics Reports, 2020 - Elsevier
Biological entities are involved in intricate and complex interactions, in which uncovering the
biological information from the network concepts are of great significance. Benefiting from …

Accurate and efficient detection of gene fusions from RNA sequencing data

S Uhrig, J Ellermann, T Walther, P Burkhardt… - Genome …, 2021 - genome.cshlp.org
The identification of gene fusions from RNA sequencing data is a routine task in cancer
research and precision oncology. However, despite the availability of many computational …

[HTML][HTML] Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive, HER2-negative …

SJ Howell, A Casbard, M Carucci, K Ingarfield… - The Lancet …, 2022 - thelancet.com
Background Capivasertib, an AKT inhibitor, added to fulvestrant, was previously reported to
improve progression-free survival in women with aromatase inhibitor-resistant oestrogen …

[HTML][HTML] The cuproptosis-related signature associated with the tumor environment and prognosis of patients with glioma

W Wang, Z Lu, M Wang, Z Liu, B Wu, C Yang… - Frontiers in …, 2022 - frontiersin.org
Background Copper ions are essential for cellular physiology. Cuproptosis is a novel
method of copper-dependent cell death, and the cuproptosis-based signature for glioma …

[HTML][HTML] Comprehensive characterization of cancer driver genes and mutations

MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta… - Cell, 2018 - cell.com
Identifying molecular cancer drivers is critical for precision oncology. Multiple advanced
algorithms to identify drivers now exist, but systematic attempts to combine and optimize …

[HTML][HTML] Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin

WW Liang, RJH Lu, RG Jayasinghe, SM Foltz… - Cancer cell, 2023 - cell.com
DNA methylation plays a critical role in establishing and maintaining cellular identity.
However, it is frequently dysregulated during tumor development and is closely intertwined …

Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma

TL Song, ML Nairismägi, Y Laurensia… - Blood, The Journal …, 2018 - ashpublications.org
Mature T-cell lymphomas, including peripheral T-cell lymphoma (PTCL) and extranodal
NK/T-cell lymphoma (NKTL), represent a heterogeneous group of non-Hodgkin lymphomas …

Glioblastoma mutations alter EGFR dimer structure to prevent ligand bias

C Hu, CA Leche, A Kiyatkin, Z Yu, SE Stayrook… - Nature, 2022 - nature.com
The epidermal growth factor receptor (EGFR) is frequently mutated in human cancer,, and is
an important therapeutic target. EGFR inhibitors have been successful in lung cancer, where …

PIK3CA variants selectively initiate brain hyperactivity during gliomagenesis

K Yu, CCJ Lin, A Hatcher, B Lozzi, K Kong… - Nature, 2020 - nature.com
Glioblastoma is a universally lethal form of brain cancer that exhibits an array of
pathophysiological phenotypes, many of which are mediated by interactions with the …